Triple

T22692795
Position Surface form Disambiguated ID Type / Status
Subject PTC Therapeutics E561093 entity
Predicate hasDrug P69332 FINISHED
Object Translarna
Translarna is a precision medicine developed by PTC Therapeutics to treat genetic disorders caused by nonsense mutations, such as certain forms of Duchenne muscular dystrophy.
 E1550454 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Translarna | Statement: [PTC Therapeutics, hasDrug, Translarna]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Translarna
Context triple: [PTC Therapeutics, hasDrug, Translarna]
  • A. Hurler
    Hurler is a wooden roller coaster at the Carowinds amusement park known for its high-speed, rough-and-tumble ride experience.
  • B. Protogeneia
    Protogeneia is a figure in Greek mythology, traditionally regarded as the daughter of Deucalion and Pyrrha and associated with the earliest generations of humankind after the great flood.
  • C. Sarepta
    Sarepta is an ancient Phoenician coastal town, known from the Bible as the place where the prophet Elijah stayed with a widow during a severe famine.
  • D. Krabbé
    Krabbé is a Dutch surname most notably associated with actor and director Jeroen Krabbé.
  • E. Trikafta
    Trikafta is a breakthrough combination therapy for cystic fibrosis that targets the underlying genetic defect to improve lung function and reduce symptoms in eligible patients.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Translarna
Triple: [PTC Therapeutics, hasDrug, Translarna]
Generated description
Translarna is a precision medicine developed by PTC Therapeutics to treat genetic disorders caused by nonsense mutations, such as certain forms of Duchenne muscular dystrophy.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Translarna
Target entity description: Translarna is a precision medicine developed by PTC Therapeutics to treat genetic disorders caused by nonsense mutations, such as certain forms of Duchenne muscular dystrophy.
  • A. Hurler
    Hurler is a wooden roller coaster at the Carowinds amusement park known for its high-speed, rough-and-tumble ride experience.
  • B. Protogeneia
    Protogeneia is a figure in Greek mythology, traditionally regarded as the daughter of Deucalion and Pyrrha and associated with the earliest generations of humankind after the great flood.
  • C. Sarepta
    Sarepta is an ancient Phoenician coastal town, known from the Bible as the place where the prophet Elijah stayed with a widow during a severe famine.
  • D. Krabbé
    Krabbé is a Dutch surname most notably associated with actor and director Jeroen Krabbé.
  • E. Trikafta
    Trikafta is a breakthrough combination therapy for cystic fibrosis that targets the underlying genetic defect to improve lung function and reduce symptoms in eligible patients.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454d71b48190a1f80af9f82b6fcf completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1789ba0148190891781d05ec64f3c completed April 29, 2026, 3:18 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0b7eccc1408190a9d2473700154bd3 completed May 18, 2026, 9:04 p.m.
NEDg Description generation batch_6a0b7fd717b88190875264662193a43a completed May 18, 2026, 9:08 p.m.
NED2 Entity disambiguation (via description) batch_6a0b807b4f748190bf4172469502c150 completed May 18, 2026, 9:11 p.m.
Created at: April 17, 2026, 3:13 p.m.